| BNR |
Burning Rock Biotech Ltd |
American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share |
11% |
|
|
994,883 |
|
Kynam Capital Management, LP |
30 Sep 2025 |
| SNDX |
Syndax Pharmaceuticals Inc |
Common Stock, par value $0.0001 per share |
10% |
$113,571,600 |
|
8,520,000 |
|
Kynam Capital Management, LP |
31 Dec 2024 |
| ENGN |
enGene Holdings Inc. |
Common Shares, no par value per share |
9.8% |
$19,976,360 |
|
4,994,090 |
|
Kynam Capital Management, LP |
31 Dec 2024 |
| CLDX |
Celldex Therapeutics, Inc. |
Common Stock, par value $0.001 |
9.8% |
$136,045,000 |
+$30,051,147 |
6,500,000 |
+28% |
Kynam Capital Management, LP |
31 Mar 2025 |
| STRO |
Sutro Biopharma, Inc. |
Common stock, $0.001 par value |
6.4% |
$0 |
|
0 |
|
Kynam Capital Management, LP |
31 Mar 2025 |
| VRDN |
Viridian Therapeutics, Inc. |
Common Stock, $0.01 par value |
5.8% |
$0 |
|
0 |
|
Kynam Capital Management, LP |
31 Mar 2025 |
| COGT |
Cogent Biosciences, Inc. |
Common Stock, par value $0.001 |
5.5% |
$113,245,430 |
|
7,886,172 |
|
Kynam Capital Management, LP |
30 Sep 2025 |
| VERA |
Vera Therapeutics, Inc. |
Class A common stock, $0.001 par value per share |
5.4% |
$83,444,698 |
|
3,426,887 |
|
Kynam Capital Management, LP |
30 Jun 2025 |
| DVAX |
DYNAVAX TECHNOLOGIES CORP |
Common Stock, par value $0.001 per share |
5% |
$71,513,102 |
|
6,560,835 |
|
Kynam Capital Management, LP |
31 Dec 2024 |
| TSVT |
2seventy Bio, Inc. |
Common Stock, par value $0.0001 per share |
0% |
$0 |
|
0 |
|
Kynam Capital Management, LP |
11 Mar 2025 |